Hakan Goker joins Merck Serono VC
This article was originally published in Scrip
Executive Summary
Hakan Goker has joined MS Ventures, the corporate venture capital arm of Merck Serono (Merck KGaA), as a director – effective from the 1 November 2013. Prior to joining the Darmstadt, Germany-based firm Dr Goker was acting as a private consultant. He previously worked at Aescap, but left the venture capital company in March this year.